$VICR

Vicor beats second-quarter expectations as backlog more than doubles despite share price decline (VICR)

Vicor (NASDAQ:VICR) reported Q2 results ahead of expectations. Adjusted EPS was $1.04 vs $0.65 expected, and revenue rose to $143.4 million vs $138.4 million expected. Backlog increased to $380 million, up 145% year over year. Shares fell about 6% premarket despite higher earnings and revenue.

Original reporting
Published Jul 22, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 10:50 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vicor beats second-quarter expectations as backlog more than doubles despite share price decline (VICR) — source image
Decision brief

The 30-second read

$VICRNeutralMed
01

Why it matters

Traders can reassess near-term demand visibility (backlog) versus profitability normalization (gross margin below the prior-year settlement-adjusted level) and the market’s apparent sensitivity to forward execution.

02

Market read

Despite an earnings and revenue beat, the stock declined pre-market, making the backlog and capacity commentary the key counterweights for positioning.

03

What to watch

The prior-year quarter benefited from a $45.0M patent settlement; investors may be recalibrating normalized profitability and watching whether margin can expand beyond 58% without one-offs.

Relevance 7/10Novelty 6/10Timing: pre-market reaction immediately after Q2 results release

Background

Vicor’s Q2 print included a strong operating cash flow rebound and a large backlog increase, alongside commentary about capacity expansion toward a second ChiP fab.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Vicor reported Q2 adjusted EPS of $1.04 vs $0.65 consensus and revenue of $143.4M vs $138.4M, yet shares fell 6.23% pre-market.

Expected impact

Near-term volatility likely persists as traders weigh the strong backlog ($380M, +145% YoY) against the pre-market selloff and margin comparisons to the prior-year patent settlement.

Evidence & confidence

The article provides the beat and the backlog jump, but does not include guidance or a new margin outlook; the only explicit risk signal is the immediate share decline despite the beat.

Market effects

Signals improving demand for power components used in high-performance compute and test equipment, potentially supportive for the broader power electronics supply chain.

No specific regional impact described.

No explicit global macro or international regulatory drivers cited.

Counterpoint

The backlog surge (+145% YoY) and improving gross margin (58.0%) may indicate the selloff is overdone absent any guidance cut in the article.

Key entities

  • Vicor Corporation

    Power components manufacturer reporting Q2 results, backlog growth, and capacity expansion plans.

  • Dr. Patrizio Vinciarelli

    CEO quoted on demand absorption and steps toward a second fab.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ:

$VICRMedAI 8/10

Vicor (NASDAQ:VICR) Reaches New 12

Vicor (NASDAQ:VICR) reached a new 52-week high on Wednesday, trading up to $334.62 and last at $332.95 versus a prior close of $267.99, with 1,586,277 shares traded. The stock also followed its April 21 quarterly results: EPS $0.44 vs $0.40 expected; revenue $112.97M vs $109.05M. Analysts cited mixed ratings and targets.

$AEHRHighAI 9/10

Here's Why Aehr Test Systems Popped Higher Today

Aehr Test Systems shares rose about 16% on the day, after Vicor unexpectedly raised its second-quarter revenue guidance, according to Vicor. Vicor cited higher product revenues and royalties from an additional licensee. Aehr, which sells wafer-level burn-in test equipment for power semiconductors and AI processors, reported a $41M hyperscaler order, lifting orders to over $92M in fiscal 2026 H2.

$VICRMedAI 9/10

Vicor (NASDAQ:VICR) Shares Gap Up – Here’s Why

Vicor (NASDAQ:VICR) shares opened higher Tuesday after closing at $267.99 and opening at $296.45; last traded at $300.85 on volume of 242,290. The move followed recent analyst target changes, including Needham raising its price objective to $260 and Roth Mkm reaffirming $245. On April 21, Vicor reported Q1 EPS of $0.44 vs $0.40 expected and revenue of $112.97M vs $109.05M.